( News & Media )
Press &
Media Coverage
Stay up to date with the latest coverage on CureMetrix, cmAngio®, and the growing field of AI-powered cardiovascular screening from mammography.
Recent Media Coverage
Setting the Standard for Detecting Risk of Heart Disease in Mammograms
Baptist Health South Florida's Lynn Women's Institute is leading the charge in using mammograms to detect heart disease risk. The initiative uses advanced AI to identify breast arterial calcifications, offering women a dual-purpose screening with no additional cost, radiation, or time.
Women's Health: Breast Arterial Calcification — The Future of Heart Disease Prevention?
A comprehensive look at how breast arterial calcification detection is reshaping cardiovascular screening for women. The article explores the clinical implications of BAC as a powerful, non-invasive marker for heart disease risk.
Press Release Archive
A comprehensive record of CureMetrix announcements, milestones, and news since our founding in 2015.
CureMetrix cmAngio Platform Reaches 400+ Clinical Sites
cmAngio, the first and only FDA-cleared AI software for breast arterial calcification detection, is now in use at more than 400 imaging centers across the United States.
CureMetrix to Present New BAC Research at RSNA 2025
CureMetrix will present findings from a multi-site study evaluating the correlation between AI-detected BAC and cardiovascular outcomes in women undergoing routine mammography screening.
Want to learn more?
Reach out to our team for additional press materials, media kits, or interview requests.
Contact Us